Hai-Cui Wu

Hai-Cui Wu


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2022 in Journal of Ovarian Research
Verified
Journal Article
Open access
PDF file
LDLi Dong
Li Dong
XXXin Xin
Xin Xin
HCHsun-Ming Chang
Hsun-Ming Chang
PLPeter C. K. Leung
Peter C. K. Leung
CYChen Yu
Chen Yu
HWHai-Cui Wu
Hai-Cui Wu
Background: Infertility is a global reproductive-health problem, and diminished ovarian reserve (DOR) is one of the common causes of female infertility. Long noncoding RNAs (lncRNAs) are crucial regulators of numerous physiological and pathological processes in humans. However, whether lncRNAs are involved in the development of DOR remains to be elucidated. Methods: Ovarian granulosa cells (OGCs) extracted from infertile women with DOR and from women with normal ovarian reserve (NOR) were subjected to high-throughput sequencing. Comprehensive bioinformatics analysis was conducted to identify the differential expression of messenger RNAs (mRNAs) and lncRNAs. Sequencing results were validated by the selection of lncRNAs and mRNAs using real-time reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Results: Compared with the NOR group, a total of 244 lncRNAs were upregulated (53 known and 191 novel), and 222 lncRNAs were downregulated (36 known and 186 novel) in the DOR group. Similarly, 457 mRNAs had differential expression between the two groups. Of these, 169 were upregulated and 288 were downregulated. Bioinformatics analysis revealed that the differentially expressed genes of mRNA and lncRNAs were considerably enriched in “cell adhesion and apoptosis”, “steroid biosynthesis”, and “immune system”. A co-expression network comprising lncRNAs and their predicted target genes revealed the possible involvement of the “thyroid hormone signaling pathway” and “protein binding, digestion and absorption” in DOR pathogenesis. The expression of SLC16A10 was positively regulated by multiple lncRNAs. After RT-qPCR validation of seven differentially expressed lncRNAs and mRNAs, respectively, the expression of lncRNA NEAT1, GNG12, ZEB2-AS1, and mRNA FN1, HAS3, RGS4, SUOX were in accordance with RNA-sequencing. Conclusions: We presented the first data showing that the expression profiles of lncRNA and mRNA in OGCs between NOR and DOR patients using RNA sequencing. The lncRNAs and mRNAs that we identified may serve as novel diagnostic biomarkers for patients with DOR.

7 January 2023 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Open access
PDF file
CWChaofeng Wei
Chaofeng Wei
SXShan Xiang
Shan Xiang
DLDanqi Liu
Danqi Liu
CWChenggang Wang
Chenggang Wang
XLXiaoyu Liang
Xiaoyu Liang
FLFang Lian
Fang Lian
Introduction: Laser-assisted hatching (LAH) is a commonly used adjunct technique; however, its effectiveness has not been fully established.Objective: We evaluated the effects of LAH on pregnancy outcomes in frozen-thawed embryo transfer (FET) cycles of cleavage-stage embryos.Materials and methods: This retrospective study involved 5779 FET cycles performed at the Reproductive and Genetic Center in the Affiliated Hospital of Shandong University of Traditional Chinese Medicine between January 2016 and December 2020. After propensity score matching, 3535 FET cycles were included, out of which 1238 were subjected to LAH while the remaining 2297 cycles were non-LAH (NLAH). The primary outcomes were clinical pregnancy rate (CPR) and live birth rate (LBR) while secondary outcomes included implantation rate (IR), biochemical pregnancy rate (BPR), ectopic pregnancy rate (EPR), pregnancy loss rate (PLR), multiple pregnancy rate (MPL), and monozygotic twinning rate (MTR). Logistic regression analysis was conducted to adjust for possible confounders. Subgroup analysis was also performed based on the endometrial preparation regimen.Results: The LAH group exhibited a higher LBR, compared to the NLAH group (34.9% vs. 31.4%, OR = 1.185, 95% CI = 1.023, 1.374,P = 0.024). Additionally, the LAH group showed a decreasing trend in PLR and EPR; however, differences were insignificant (P = 0.078,P = 0.063 respectively). Differences in IR (24.6% vs. 24.3%), BPR (41.8% vs. 40.4%), CPR (40.7% vs. 38.3%), MPR (14.1% vs. 17.3%), and MTR (1.4% vs. 1.1%) were insignificant. Subgroup analysis revealed that LAH may be more conducive for pregnancy outcomes in hormone replacement cycles.Conclusions: In summary, LAH has an increased chance of achieving live births. However, further prospective studies should be performed to confirm our findings.

7 December 2024 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Open access
PDF file
WCWen Chen
Wen Chen
LDLi Dong
Li Dong
CWChaofeng Wei
Chaofeng Wei
HWHai-Cui Wu
Hai-Cui Wu
Diminished ovarian reserve (DOR) is characterized by a decrease in the number and quality of oocytes, with its incidence increasing annually. Its pathogenesis remains unclear, making it one of the most challenging problems in the field of assisted reproduction. Epigenetic modification, a molecular mechanism affecting genomic activity and expression without altering the DNA sequence, has been widely studied in reproductive medicine and has attracted considerable attention regarding DOR. This review comprehensively examines the various epigenetic regulatory changes in ovarian granulosa cells (OGCs) and oocytes during DOR. DNA methylation plays a crucial role in regulating granulosa cell function, hormone production, and oocyte development, maturation, and senescence. Histone modifications are involved in regulating follicular activation, while non-coding RNAs, such as long noncoding RNAs (lncRNAs) and microRNAs (miRNAs), regulate granulosa cell function and oocyte development. N6-methyladenosine (m6A) modifications are associated with age-related oocyte senescence. Epigenetic clocks based on DNA methylation show potential in predicting ovarian reserve in DOR. Furthermore, it discusses the potential for utilizing epigenetic mechanisms to better diagnose and manage DOR.

21 March 2017 in Chromatographia
Verified
Journal Article
Closed access
PDF file
ZSZhengao Sun
Zhengao Sun
HWHai-Cui Wu
Hai-Cui Wu
FLFang Lian
Fang Lian
XZXingxing Zhang
Xingxing Zhang
CPconghui Pang
conghui Pang
LHLetian Han
Letian Han

11 November 2024 in Journal of Ovarian Research
Verified
Journal Article
Open access
PDF file
XXXin Xin
Xin Xin
LDLi Dong
Li Dong
JLJiaxi Li
Jiaxi Li
WCWen Chen
Wen Chen
YQYue Qiu
Yue Qiu
HWHai-Cui Wu
Hai-Cui Wu
Infertility is a reproductive health problem that attracts worldwide attention. Polycystic ovary syndrome (PCOS) is a major cause of female infertility and patients with obesity and PCOS are particularly common in clinical practice. Long non-coding RNA (lncRNAs) are a functional core in cells that regulate gene expression, transcription, and chromatin modification processes, and participate in epigenetics, cell cycle, and cell differentiation. LncRNAs are assumed to play a role in the occurrence and development of PCOS; however, their specific mechanism of action remains to be elucidated. High-throughput sequencing technology has been used to sequence and analyze lncRNAs in exosomes from the follicular fluid of patients with obesity and PCOS and those who underwent assisted reproductive therapy owing to male factors. Specific expression profiles of patients with obesity and PCOS were obtained and functional information analysis combined with a literature review were performed to screen for differentially expressed lncRNAs, which were validated using real-time reverse transcription quantitative polymerase chain reaction (RT-qPCR). High-throughput sequencing analysis revealed that compared to normal patients with male infertility, patients with obesity and PCOS had a total of 20 lncRNAs with significant expression differences in follicular fluid exosomes. Among them, 17 lncRNAs were upregulated and three were downregulated. Functional analysis showed that differentially expressed genes were mainly enriched in “cell metabolism,” “cell adhesion,” and other aspects: related gene pathways mainly involved Huntington’s disease, Parkinson’s disease, spliceosomes, non-alcoholic fatty liver disease, and ribosomes. Verification of differentially expressed lncRNAs revealed that the expression of lncRNAs TPT1-AS1, PTOV1-AS1, PTPRG-AS1, and SNHG14 in follicular fluid exosomes was consistent with the sequencing results. A preliminary differential expression profile of lncRNAs in exosomes of patients with obesity and PCOS was established by transcriptomic analysis of these individuals. Our bioinformatics analysis results may be applicable to further study of the impact mechanism involving obesity and PCOS. These differentially expressed lncRNAs maybe served as potential biomarkers for in-depth studies of the occurrence, development on Follicle quality and function for patients with PCOS in the future.

12 December 2025 in Annals of Medicine
Verified
Journal Article
Open access
XXXin Xin
Xin Xin
LDLi Dong
Li Dong
JLJiaxi Li
Jiaxi Li
JZJinfu Zhang
Jinfu Zhang
HWHai-Cui Wu
Hai-Cui Wu
Cellular senescence is often linked to diseases or states of dysfunction, including reproductive disorders caused by ovarian dysfunction. It plays a significant role in conditions like polycystic ovary syndrome (PCOS). However, the specific effects and potential mechanisms of cellular senescence in PCOS need to be elucidated. This review comprehensively consolidates evidence from original research articles and systematic reviews to explore the association between PCOS and cellular senescence, particularly emphasizing cell senescence markers and mechanisms linked to various PCOS phenotypes. In addition, it also covers potential mechanisms and advances in cellular senescence-related treatment methods in PCOS. Current evidence suggests that cellular senescence might contribute to PCOS through mechanisms such as replicative senescence, stress-induced premature senescence, and immunoinflammatory responses mediated by senescent cells. Key features of senescence, including cell cycle arrest, the senescence-associated secretory phenotype (SASP), epigenetic changes, abnormal cell morphology, oxidative stress, DNA damage from telomere shortening and telomerase inhibition, and overactivation of anti-apoptotic pathways, are all related to PCOS. These mechanisms might especially impair follicular development in obese, hyperandrogenic, or insulin-resistant patients with PCOS, leading to endometrial hyporeceptivity and increased pregnancy complications. Senolytic and senomorphic drugs are valuable clinical treatments for PCOS respectively targeted to immune surveillance mechanisms of senescent cells or mitigated the harmful effects of senescent cells on intercellular communication. There is a complex correlation mechanism between cellular senescence and PCOS. Studying these cellular senescence markers and mechanisms in PCOS could provide new insights into the pathogenesis, and lay the groundwork for in-depth study and potential application of anti-senescence therapies in treating PCOS.